CPHI North America continues its tradition of being the nexus where the world’s largest healthcare economy converges with global pharma markets, ingredients suppliers, and the entire supply chain. This year, the event will be held from 7-9 May 2024, bringing together a diverse array of industry leaders, innovators, and developers at the Pennsylvania Convention Center, Philadelphia. As the heart of US drug development and manufacturing, CPHI North America serves as an indispensable platform for fostering collaborations and showcasing cutting-edge advancements in the pharmaceutical industry.

Who can you expect to meet?

The 2024 edition of CPHI North America is expected to draw thousands of pharma professionals from over 101 countries, with 75% of attendees holding purchasing power and 48% representing the C-Suite. With a focus on connecting industry pioneers, fostering knowledge exchange, and facilitating business transactions, the event promises to be a dynamic and enriching experience for all participants and for more than 250 exhibitors.

Exhibitors at CPHI North America will represent the entire pharmaceutical supply chain, including clinical trial supply, ingredients manufacturing, packaging, biologics, and finished products. The event offers a unique opportunity to explore the latest innovations, forge strategic partnerships, and gain insights into emerging trends shaping the industry. Interest in the US market has never been higher, with the country ranking as the top destination for innovation and manufacturing in the recent CPHI Annual Survey.

The event platform

To optimize your experience at CPHI North America, be sure to download the CPHI app. This essential tool provides access to the Event Platform, including features such as pre-planning your schedule, connecting with other participants, and exploring exhibitor offerings. Plus, with the app, you can access the audio of our new silent theaters, ensuring you don’t miss out on any valuable insights.

The right badge for you:

At CPHI North America, the aim is to ensure that every attendee has a personalized experience tailored to their purpose for attending. To achieve this goal, a qualification process is being introduced during registration this year. The information provided by attendees will assist in determining the badge options available to them. By making the right connections, building better relationships, and taking advantage of the offerings at the show, attendees can have the best possible experience.

There are a variety of pass options to meet specific needs:

• Attendee: This pass allows attendees to meet peers in production, procurement, supply chain, and R&D, while discovering innovations and insights from over 250 exhibits in their field.
• Attendee VIP: This pass provides a first-class experience, granting access to the event, exclusive VIP areas, complimentary refreshments, and more.
• Networking Foundations: This pass is tailored for Sales, Marketing, and Business Development professionals, offering an opportunity to explore the networking potential and learning opportunities available at CPHI North America.
• Networking Accelerator: Designed especially for Sales, Marketing, and Business Development professionals, this pass is the ultimate choice for boosting networking efforts, providing enhanced connections before, during, and after the event.

CPHI North America: New Content Opportunities

This year’s CPHI North America introduces two new tracks, alongside other engaging content additions, offering attendees a comprehensive exploration of the latest trends and innovations in the pharmaceutical industry:

1. *NEW* Sustainable Futures Track:
Addressing the pressing need for environmentally conscious practices in pharmaceutical manufacturing, the Sustainable Futures Track covers green chemistry, sustainable supply chains, and the industry’s journey towards a greener future. Keynote speaker Jim Massey, Chief Sustainability Officer at Zai Lab, will provide insights into accelerating the path to net-zero emissions, offering actionable strategies for integrating sustainability into operations.

2. *NEW* Exploring Excipients Track:
Highlighting the critical role of excipients in drug development, the Exploring Excipients track sheds light on excipient innovation, quality standards, and their impact on drug efficacy. Keynote speakers Nigel Langley, Global Technical Director at Gaylord Chemical LLC, and Joseph Zeleznik, Board Member & Chair at IPEC-Americas, will discuss the importance of excipient grade in pharmaceutical drug development, offering invaluable insights into excipient innovation.

3. Supply Chain Economy:
The Supply Chain Economy track explores how patient advocacy, patient-centric design, and partnerships are reshaping the global pharmaceutical supply chain to ensure universal access. From utilizing data analytics to understanding and addressing supply chain vulnerabilities, attendees will gain valuable insights into enhancing supply chain efficiency and navigating regulatory changes.

4. Revolutionizing Drug Manufacturing:
Delving into innovative approaches to streamline drug production and accelerate time to market, the Revolutionizing Drug Manufacturing track covers topics such as tech transfer, process performance qualification, and lean automation. Attendees will explore the impact of new technologies and AI challenges on drug manufacturing, gaining valuable insights from industry experts.

Top 3 Speaker Highlights:
1. Jim Massey, Chief Sustainability Officer at Zai Lab: Keynote speaker for the Sustainability Track, providing insights into accelerating the path to net-zero emissions.
2. Nigel Langley, Global Technical Director at Gaylord Chemical LLC, and Joseph Zeleznik, Board Member & Chair at IPEC-Americas: Keynote speakers for the Exploring Excipients Track, discussing the importance of excipient grade in pharmaceutical drug development.
3. Dave Powell, Vice President of Business Development at Grand River Aseptic Manufacturing, and Anil Kane, Executive Director, Global Head of Technical Affairs at Thermo Fisher Scientific: Industry experts participating in the CDMO Panel Discussion, offering invaluable insights into outsourcing trends and technological advancements in pharmaceutical manufacturing.

*NEW* The Start-Up Market: This year, the organisers have introduced ‘The Start-Up Market’, a dedicated space where Start-Ups, innovators, and small enterprises from the industry can exhibit their exciting new products and solutions. The Start-Up Market is the space to visit to discover new innovations and connect with companies at the cutting edge of the pharma industry. Eligible companies classified as “Start-Ups” and active in the pharma, biopharma, digital, or medical device sectors can exhibit.

Exhibitor Spotlight: Immerse yourself in a showcase of the latest product innovations and solutions from leading exhibitors in the pharmaceutical industry. From groundbreaking technologies to novel formulations, exhibitor spotlights offer a firsthand glimpse into the future of pharmaceutical development and manufacturing, providing attendees with invaluable insights to fuel innovation and drive business growth.

Start-Up Pitches: Discover the next wave of pharmaceutical innovators as start-up companies pitch their groundbreaking ideas and technologies to industry leaders and investors. From disruptive therapies to cutting-edge technologies, start-up pitches offer a glimpse into the future of healthcare innovation, providing attendees with unique opportunities to identify potential investment opportunities and strategic partnerships.

*NEW* Diversi’tea’
Diversity stands as a multifaceted challenge within the pharmaceutical industry, with significant implications for clinical trials, leadership roles, and overall innovation. The lack of diversity in clinical trials, where 75% of participants for novel drugs were Caucasian, can affect medication efficacy and safety across diverse populations. Additionally, only about 10% of CEO roles in the biotech sector are held by women, highlighting broader diversity issues in leadership. Embracing diversity is crucial for fostering an inclusive environment that fuels groundbreaking innovation. This transformative “High-Tea Diversity Event” offers a unique platform to glean insights from leaders who have navigated diversity challenges, fostering innovative solutions. Attendees will engage in thought-provoking discussions aimed at uncovering pathways to a more inclusive future. The keynote, “The Role of Diversity in Shaping the Future,” emphasizes the importance of diversity and inclusion, especially during challenging times, citing research showing the positive impact on profitability. Following this, discussions on various aspects of diversity, including the voices of women in pharma and driving patient-centricity, promise to provide actionable strategies for industry-wide transformation. Join us at CPHI North America for this free event to network, exchange ideas, and explore ways to embed diversity into the future of the North American pharma industry.